Drug Trial Radar · NCT07085767
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Last checked: Nov 19, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Nov 3, 2025
Primary completion
Dec 2028
Study completion Jan 2032
Sponsor
- Lead sponsor
- Olema Oncology, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Novartis Pharmaceuticals
- First posted
- Jul 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase 3 clinical trial compares the efficacy and safety of palazestrant with ribociclib to letrozole and ribociclib in women and men who have not received prior systemic anti-cancer treatment for advanced breast cancer.
Conditions
- Breast Cancer
- Locally Advanced Breast Cancer
- Metastatic Breast Cancer
- ER Positive Breast Cancer
- HER2 Negative Breast Carcinoma
Interventions
PalazestrantDrug
Participants will be treated with palazestrant 90 mg once daily on a 4-week (28-day) cycle.
Letrozole-matching placeboDrug
Participants will be treated with letrozole-matching placebo once daily on a 4-week (28 day) cycle
RibociclibDrug
Participants will be treated with ribociclib 600 mg once daily on Days 1-21 of a 4-week (28 day) cycle.
LetrozoleDrug
Participants will be treated with letrozole 2.5 mg once daily on a 4-week (28-day) cycle
Palazestrant matching-placeboDrug
Participants will be treated with palazestrant-matching placebo once daily on a 4-week (28-day) cycle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS)Time frame: From Date of Randomization until Disease Progression or Death Due to Any Cause (estimated as up to 3.5 years)
Locations
200 sites in 23 countries. Site status is shown where the registry gives one.
Clinical Trial Site
Hot Springs, Arkansas · Recruiting
Clinical Trial Site
Beverly Hills, California · Recruiting
Clinical Trial Site
La Jolla, California · Recruiting
Clinical Trial Site
Los Alamitos, California · Recruiting
Clinical Trial Site
Oakland, California · Recruiting
Clinical Trial Site
Roseville, California · Recruiting
Clinical Trial Site
San Francisco, California · Recruiting
Clinical Trial Site
San Francisco, California · Recruiting
Clinical Trial Site
Santa Barbara, California · Recruiting
Clinical Trial Site
Santa Clara, California · Recruiting
Clinical Trial Site
Vallejo, California · Recruiting
Clinical Trial Site
Walnut Creek, California · Recruiting
Clinical Trial Site
Aurora, Colorado · Recruiting
Clinical Trial Site
Denver, Colorado · Recruiting
Clinical Trial Site
New Haven, Connecticut · Recruiting
Clinical Trial Site
Tampa, Florida · Recruiting
Clinical Trial Site
Marietta, Georgia · Recruiting
Clinical Trial Site
Honolulu, Hawaii · Recruiting
Clinical Trial Site
Peoria, Illinois · Recruiting
Clinical Trial Site
Urbana, Illinois · Recruiting
Clinical Trial Site
Ames, Iowa · Withdrawn
Clinical Trial Site
Scarborough, Maine · Recruiting
Clinical Trial Site
Annapolis, Maryland · Recruiting
Clinical Trial Site
Baltimore, Maryland · Recruiting
Clinical Trial Site
Baltimore, Maryland · Recruiting
Clinical Trial Site
Catonsville, Maryland · Recruiting
Clinical Trial Site
Burlington, Massachusetts · Recruiting
Clinical Trial Site
Ann Arbor, Michigan · Recruiting
Clinical Trial Site
Minneapolis, Minnesota · Recruiting
Clinical Trial Site
Jackson, Mississippi · Recruiting
Clinical Trial Site
Kansas City, Missouri · Recruiting
Clinical Trial Site
Lebanon, New Hampshire · Recruiting
Clinical Trial Site
Santa Fe, New Mexico · Recruiting
Clinical Trial Site
New York, New York · Recruiting
Clinical Trial Site
New York, New York · Recruiting
Clinical Trial Site
Charlotte, North Carolina · Recruiting
Clinical Trial Site
Durham, North Carolina · Recruiting
Clinical Trial Site
Cincinnati, Ohio · Recruiting
Clinical Trial Site
Columbus, Ohio · Recruiting
Clinical Trial Site
Columbus, Ohio · Recruiting
Showing 40 of 200 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.